Easy Test for
Visceral Leishmaniasis and Post-Kala-azar Dermal Leishmaniasis
To the Editor: Diagnosis of visceral leishmaniasis (VL), fatal if untreated, is complex because the symptoms are the same for many fever-associated ailments. Despite limitations, diagnosis remains based on fi nding Leishmania amastigotes in spleen and/or bone marrow aspirates (1) . Sophisticated laboratory methods, although sensitive, are costly. The immunochromatographic strip test that uses recombinant K39 antigen (rK39), although satisfactory in India, is less sensitive in Africa, Latin America, and Mediterranean regions (2) . Post-kala-azar dermal leishmaniasis (PKDL), a sequel to VL in India and Africa, is often confused with other skin diseases (3, 4 We developed a diagnostic ELISA with modifi cations of our previous method (6) . Microtiter plates were coated with 2.5 μg LAg at pH 7.5 (100 μL/well) and kept at 4°C overnight, after which they were blocked with 1% bovine serum albumin, dried, and stored at 4°C as precoated plates. The assay performed at room temperature took ≈2.5 h. Test and control serum samples (1:1,000 dilution, 100 μL/ well) were applied to the plates for 45 min and shaken occasionally. Horseradish peroxidase-conjugated goat anti-human immunoglobulin (Ig) G (Genei, Bangalore, India) was applied at 1:5,000 (100 μL/well) for 45 min. Color development with orthophenylenediamine (Sigma-Aldrich, St. Louis, MO, USA) was allowed for 5-10 min. Positive results were determined by comparing colors with those on a card previously prepared for positive and negative wells. ELISA, performed for the VL and PKDL patients from India, was 100% sensitive (percentage of patients with confi rmed disease and positive test results) and 96.3% specifi c (percentage of negative controls with negative test results) ( Figure, panel  A) ; sensitivity and specifi city were higher than that reported earlier (6) and by other studies that used crude leishmanial antigens (2) . One sample from each of fi lariasis, lymphoma, and disease-endemic area controls was marginally false positive. Seropositivity was diagnosed for 1 patient who had a negative spleen aspirate but clinical signs of VL and for 1 patient who refused spleen or bone marrow aspiration.
To avoid any visible crossreaction in the dipstick assay, we optimized LAg concentration, test serum dilution, and control serum dilution. Optimum concentration for human studies is 500 μg/mL LAg, 1:2,000 serum dilutions, 1:2,000 horseradish peroxidase-conjugated goat anti-human IgG, and 15 mg 3,3′-diaminobenzidine (SigmaAldrich) as substrate in 30 mL Trisbuffered saline. LAg was bound to a long nitrocellulose piece at the test line (line on which LAg is coated). Goat anti-human IgG (Genei) at 1:25 was coated as an internal control line. Free sites were blocked with 2% bovine serum albumin containing 0.01% NaN 3 and were air dried. LAgcoated membranes were affi xed to the end of a plastic support (with a free end as handle) with double-adhesive tape, cut into 4-mm-wide sticks, and stored at room temperature. During the testing process at room temperature, dipsticks were incubated in diluted serum for 30 min, washed 2×, incubated for 30 min with secondary antibody, washed 3×, and incubated in substrate solution for 1 min. Finally, dipsticks were washed in water, dried on tissue paper, and examined for specifi c reaction. When stored at room temperature without desiccation, dipsticks performed consistently for 12 months. Dipsticks appeared equally sensitive and specifi c (100%) for VL from India and Brazil and for PKDL. Because internal control lines remained positive, analyses were considered valid ( Figure, panel B) .
LAg dipsticks are more sensitive for diagnosing VL in Brazil than rK39 (7) and cost ≈70× less (8) . Although further validation with a larger sample size and healthy controls from diseaseendemic areas and controls for other diseases is warranted, these easy, simple, and low-cost methods could emerge as effi cient tools for diagnosis of VL and PKDL. To the Editor: Amebic keratitis is an aggressive infection usually associated with soft contact lenses, and its poor outcome can lead to a corneal graft (1) . Ameba can host ameba-resistant bacteria (2) and serve as a source for numerous organisms to exchange DNA, adapt to changing environments, and become pathogenic to the host (3). However, mixed keratitis caused by amebae in association with ameba-resistant pathogens is rarely seen.
A 17-year-old woman who was myopic and had worn soft contact lenses for 3 years consulted our ophthalmology department for pain and redness of the left eye that had persisted for 2 weeks. No visual loss was reported, and a slit-lamp examination showed a millimetric epithelial defect associated with a round stromal infi ltrate (Figure) . No intraocular reaction was observed, and bacterial keratitis was diagnosed. Her condition improved after a 7-day topical fl uoroquinolone treatment, and follow-up at 13 months showed only a slight superfi cial stromal scar. The patient reported that she had inappropriately worn monthly contact lenses for 3 months, cleaned and rinsed lenses with a commercial cleaning solution but diluted the solution with tap water, and washed her hands with tap water but did not dry them before handling the lenses.
Results of microbiologic analysis of a corneal scraping, which included molecular detection of ameba (18S rDNA), bacteria (16S rDNA), and herpesvirus (DNA polymerase), were negative. However, culture of contact lens storage case liquid in Page-modifi ed Neff ameba saline enriched with heat-killed Enterobacter aerogenes (2) identifi ed Pseudomonas fl uorescens and Stenotrophomonas maltophilia, both of which were identifi ed by matrixassisted laser desorption ionization time-of-fl ight mass spectrometry (4); Mycobacterium chelonae, which was identifi ed by rpoB gene sequencing; and Acanthamoeba polyphaga, which was identifi ed by partial 18S rDNA sequencing.
Culturing this ameba in sterile peptone-yeast extract-glucose broth showed that it hosted 4 organisms. The fi rst organism was a new intracellular Deltaproteobacterium provisionally named Candidatus Babela massiliensis (100% 16S rDNA sequence similarity with a reference strain [GenBank accession no. GQ495224], which was susceptible to 200 μg/mL rifampin and resistant to 20 μg/mL ciprofl oxacin). The second organism was a new, unnamed, gram-negative, ciprofl oxacin-susceptible (20 μg/mL) Alphaproteobacterium bacillus with 99% 16S rDNA sequence similarity (GenBank accession no. HM138368) with Candidatus Odyssella sp. and Acanthamoeba endosymbiont KA/ E9 (5). The third organism was a new giant virus related to an A. polyphaga mimivirus (6) strain Lentille. The
